Ascidian Therapeutics and Forge Biologics have partnered to advance the development and manufacturing of ACDN-01.

Ascidian Therapeutics ("Ascidian"), a biotechnology company seeking to treat human diseases by rewriting RNA, and Forge ...

Nikon SLM Solutions has officially released the SLM.Prep next-generation data preparation software for its portfolio of metal ...

"Over the past decade, Uzbekistan’s economy has undergone an accelerated process of qualitative and systemic transformation." ...

The current foreign policy of the United States, particularly after its withdrawal from the Paris Agreement for a second time ...

IonQ’s investment thesis is neutral-to-bullish, supported by a full-stack platform strategy and a $1B-plus commercial ...

Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and StudiesAUSTIN, Texas, Jan.

Bayer's agrochemicals unit Monsanto has filed lawsuits in the US against the manufacturers of mRNA-based COVID-19 vaccines, ...

While in the mid-2010s the country’s nominal gross domestic product stood at approximately USD 60-65 billion, it has now ...

Chris is an exceptional fit to lead the ElevateBio team to capture the momentum of the genetic medicine industry’s next wave of expansion,” said David Hallal, Executive Chairman of ElevateBio. “His ...

Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and Studies AUSTIN, Texas, Jan. 7, 2026 /PRNewswire/ -- Genprex, Inc.

Enthusiasts thought the discovery that graphene, a form of carbon, could be extracted from graphite would change the world.